Minimally Invasive Surgery for Left-Sided Pancreatic Cancer: Long-Term Safety Confirmed by DIPLOMA Trial
Highlight
The recent multicenter randomized DIPLOMA trial establishes that minimally invasive left pancreatectomy for patients with resectable pancreatic ductal adenocarcinoma in the body and tail yields equivalent overall survival and disease-free survival compared to open surgery. Both approaches deliver similar rates of adjuvant therapy administration and timing, reinforcing the long-term oncologic safety of minimally invasive approaches when adhering to rigorous surgical principles.
Study Background
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.